Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Neurologist, MsC candidate, PhD candidate at Clinical centre of Montenegro, Montenegro

Dr. Sanja V. Gluscevic is a distinguished neurologist and medical professional based in Montenegro. She holds a medical degree from the University of Montenegro and completed her neurology residency at the University of Belgrade. Dr. Gluscevic has demonstrated significant leadership, serving as the first Montenegrin ambassador for neurology and brain health at the European Academy of Neurology, and as an ambassador for the Sumaira Foundation. She is also the founder of the Montenegrin Association for Brain Diseases, HOPE, and holds several prominent positions in clinical and educational settings, including teaching assistant roles and leadership in various medical organizations. Her extensive expertise spans multiple sclerosis, epilepsy, and other neurological conditions, with numerous publications in reputable medical journals. Dr. Gluscevic is actively involved in international collaborations and advocacy for neurological health, contributing to research, policy, and patient care advancements in Montenegro and beyond.

Professional Profile 

Education

Dr. Sanja V. Gluscevic’s educational background is rooted in both her medical and specialized neurological training. She completed her medical degree at the University of Montenegro, where she laid the foundation for her career in healthcare. Following her graduation, Dr. Gluscevic pursued advanced studies in neurology at the University of Belgrade, where she completed her neurology residency. During her education, she focused on various aspects of neurology, including the diagnosis and treatment of complex brain diseases such as multiple sclerosis and epilepsy. Beyond formal education, Dr. Gluscevic actively engaged in additional professional development through international training programs, conferences, and workshops, enhancing her expertise in neurology. Her academic achievements and continued commitment to learning have not only shaped her clinical career but have also fueled her contributions to neurological research, advocacy, and education, making her a prominent figure in the field of neurology in Montenegro and internationally.

Professional Experience

Dr. Sanja V. Gluscevic has an extensive professional background in neurology, making significant contributions to both clinical practice and research. She has worked at prominent medical institutions in Montenegro, providing exceptional care for patients with a wide range of neurological conditions, particularly focusing on multiple sclerosis, epilepsy, and neurodegenerative diseases. Her role as a neurologist includes diagnosing, treating, and managing chronic neurological disorders, offering personalized care to improve patient quality of life. Dr. Gluscevic has also been involved in various research initiatives, exploring innovative approaches to neurological treatments and working on projects aimed at enhancing the understanding of neurological diseases. She has participated in numerous international clinical trials and collaborated with research teams worldwide to bring new treatments to the forefront. Her leadership in the medical community extends to her involvement in educational programs, where she mentors and trains future neurologists, sharing her expertise and passion for advancing the field of neurology.

Research Interest

Dr. Sanja V. Gluscevic’s research interests primarily focus on the understanding and treatment of neurological disorders, with a particular emphasis on multiple sclerosis, epilepsy, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Her research aims to uncover the underlying mechanisms of these diseases, exploring their pathophysiology and potential therapeutic strategies. She is particularly interested in the role of immune system dysfunction and neuroinflammation in the progression of neurological conditions. Dr. Gluscevic’s work also delves into the exploration of novel biomarkers for early diagnosis and monitoring disease progression. Additionally, she has been actively involved in clinical trials evaluating the efficacy of emerging treatments and pharmacological interventions. Through her research, Dr. Gluscevic strives to develop more effective, personalized treatment approaches to improve patient outcomes. Her contributions to the field of neurology aim to bridge the gap between laboratory findings and clinical applications, advancing both scientific knowledge and patient care.

Award and Honor

Dr. Sanja V. Gluscevic has received numerous prestigious awards and honors throughout her distinguished career, recognizing her contributions to the field of neurology and neuroscience. She has been acknowledged for her outstanding research in the areas of neurological diseases and neuroinflammation, particularly in relation to multiple sclerosis and neurodegenerative conditions. Among her accolades, Dr. Gluscevic has received research grants from prominent institutions, enabling her to further her investigations into innovative treatment strategies for neurological disorders. Her work has been recognized with invitations to present at international conferences, underscoring her status as a leading expert in the field. Dr. Gluscevic has also been awarded fellowships and awards for excellence in clinical research, contributing significantly to advancements in therapeutic development. Through these honors, she has gained widespread recognition for her pioneering research and her efforts to enhance patient care and scientific understanding of complex neurological diseases.

Research Skill

Dr. Sanja V. Gluscevic possesses a diverse and extensive skill set in research, which has greatly contributed to her success in the field of neurology and neuroscience. Her expertise includes a strong background in both basic and clinical research, with particular emphasis on neuroinflammation, neurodegeneration, and the pathophysiology of neurological disorders such as multiple sclerosis. Dr. Gluscevic is highly proficient in experimental design, utilizing a range of advanced techniques such as molecular biology, immunohistochemistry, and imaging technologies to investigate neurological processes at the cellular and molecular levels. She has a keen ability to translate laboratory findings into clinical applications, bridging the gap between experimental research and patient care. Additionally, her data analysis skills are complemented by her use of sophisticated computational tools for interpreting complex datasets. Dr. Gluscevic’s collaborative nature and leadership in interdisciplinary teams further enhance her ability to conduct innovative, high-impact research.

Conclusion

Sanja V. Gluscevic is a highly qualified candidate for the Best Researcher Award, demonstrating strong leadership, a diverse skill set, and a commitment to advancing research in neurology. Her publication record, advocacy work, and extensive experience in both education and clinical practice solidify her credentials. To further enhance her profile, expanding international collaborations and strengthening her impact on clinical practice would make her an even more formidable contender for the award. Overall, Gluscevic has proven herself to be a leading figure in her field, making significant contributions to both the research community and the broader healthcare landscape.

Publications Top Noted

  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Emine Rabia Koc, Gizem Güllü, Furkan Saridas, Sanja Gluscevic, Belkıs Coskun, Yavuz Pehlivan, Fatma Zehra Calikusu, Omer Faruk Turan
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07198-7
  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Koc Emine Rabia, Güllü Gizem, Saridas Furkan, Gluscevic Sanja, Coskun Belkıs Nihan, Pehlivan Yavuz, Calikusu Fatma Zehra, Turan Omer Faruk
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07118-9
  • Title: Sex-Specific Associations between Thyroid Status, Inflammation and Hemostasis Biomarkers in Patients with Subacute Thyroiditis
    Authors: Jelena Vekic, Aleksandra Klisic, Jelena Kotur-Stevuljevic, Neda Milinkovic, Sanja Gluscevic, Serpil Ciftel, Filiz Mercantepe
    Year: 2024
    Citation: Biomedicines, DOI: 10.3390/biomedicines12081862
  • Title: Cardiometabolic Risk Factors Related to Atrial Fibrillation and Metabolic Syndrome in the Pakistani Population
    Authors: Saira Rafaqat, Saima Shariif, Shagufta Naz, Sanja Gluscevic, Filiz Mercantepe, Ana Ninic, Aleksandra Klisic
    Year: 2024
    Citation: Medicina, DOI: 10.3390/medicina60081190

Fatemeh Akbarzadeh | Physics in Medicine | New Horizons Science Invention Award

Posted on by ScienceFather

Mrs. Fatemeh Akbarzadeh | Physics in Medicine | New Horizons Science Invention Award

Medical Physicist at Guilan University of Medical Sciences, Iran

Fatemeh Akbarzadeh is a medical physicist from Rasht, Guilan, Iran, specializing in cancer treatment, targeted therapy, and drug delivery. With a strong academic background, she has made significant contributions to research and innovation in her field. Fatemeh has a robust publication record, with several papers in reputable journals and a patent for synthesizing bismuth oxide nanoparticles for targeted drug delivery. Her professional experience includes roles as a medical physicist in various hospitals, where she has applied her knowledge to enhance cancer treatment protocols. Fatemeh’s research interests encompass various cutting-edge areas, including photodynamic therapy, radiation therapy, and nanotechnology. She is dedicated to advancing cancer diagnostics and treatment, making her a prominent figure in her field. With her commitment to research, Fatemeh is well-equipped to contribute significantly to the scientific community and healthcare innovation.

Professional Profile

Education✍️

Fatemeh Akbarzadeh’s educational journey reflects her dedication to the field of medical physics and radiotherapy technology. She earned her Master of Science in Medical Physics from Kermanshah University of Medical Sciences in 2018, achieving an impressive GPA of 3.953 out of 4.00 (18.76 out of 20). This academic excellence showcases her strong grasp of complex concepts and methodologies in medical physics. Prior to her Master’s degree, she completed her Bachelor of Science in Radiotherapy Technology at Tehran University of Medical Sciences in 2014, graduating with a GPA of 3.670 out of 4.00 (17.20 out of 20). This foundational education equipped her with essential skills and knowledge, laying the groundwork for her research and professional pursuits. Throughout her studies, Fatemeh honed her abilities in both theoretical and practical aspects of medical physics, which would later influence her research interests and professional roles. Her educational achievements demonstrate her commitment to excellence and a passion for advancing healthcare through scientific research.

Professional Experience♻️

Fatemeh Akbarzadeh’s professional experience spans several roles in medical physics, highlighting her expertise in the field. Currently, she serves as a medical physicist in the Department of Radiotherapy at Razi Hospital in Rasht, Guilan, where she has been employed since 2024. In this role, Fatemeh applies her knowledge to enhance cancer treatment protocols and ensure patient safety through effective radiation management. Previously, she worked as a medical physicist at Velayat Hospital in Qazvin from 2021 to 2024 and at Razi Hospital from 2019 to 2021. These positions have provided her with hands-on experience in clinical settings, allowing her to integrate her research findings into practical applications. Additionally, Fatemeh held the position of laboratory expert in the Toxicology and Pharmacology Department at Kermanshah University of Medical Sciences from 2017 to 2018, where she conducted various experiments under the supervision of Dr. Leila Hosseinzadeh. Her diverse experiences in both laboratory and clinical environments have equipped her with a comprehensive understanding of medical physics and its applications in cancer treatment.

Research Interest🧬

Fatemeh Akbarzadeh’s research interests center on advancing cancer treatment and diagnosis through innovative technologies and methodologies. She focuses on several key areas, including cancer treatment, targeted therapy, drug delivery systems, photodynamic therapy, and radiation therapy. Her work often explores the integration of nanotechnology in cancer diagnosis and treatment, aiming to improve therapeutic efficacy and minimize side effects. In addition to her interest in treatment modalities, Fatemeh is keen on studying radiobiology and dosimetry, which are critical for optimizing radiation therapy techniques. She has contributed significantly to the field through her publications, addressing topics such as the cytotoxicity of bismuth oxide nanoparticles and their application in photodynamic therapy. By investigating the interplay between novel drug delivery systems and traditional cancer treatments, Fatemeh seeks to enhance patient outcomes and contribute to the development of more effective therapeutic strategies. Her dedication to research and innovation positions her as a promising figure in the realm of cancer treatment and medical physics.

Award and Honors🏆

Fatemeh Akbarzadeh’s contributions to the field of medical physics and cancer research have garnered her recognition and honors throughout her academic and professional career. One of her notable achievements is obtaining an Iranian patent for the synthesis of bismuth oxide nanoparticles for targeted drug delivery, which signifies her innovative approach to addressing challenges in cancer treatment. Her research has also been recognized at various conferences, where she has presented her findings on the cytotoxicity of nanoparticles and their potential applications in photodynamic therapy. Fatemeh’s commitment to excellence in research is further evidenced by her high academic performance during her studies, where she graduated with distinction in both her bachelor’s and master’s programs. These accomplishments reflect her dedication to advancing the field of medical physics and contribute to her growing reputation as a researcher and medical physicist. As she continues to publish and present her work, Fatemeh is likely to receive further accolades and recognition for her innovative contributions to cancer research and treatment.

Conclusion

Fatemeh Akbarzadeh is a strong candidate for the New Horizons Science Invention Award due to her academic accomplishments, innovative research, and practical experience in medical physics. Her contributions to cancer treatment and diagnostics through targeted therapies and nanotechnology position her at the forefront of her field. By addressing the areas for improvement, particularly in collaboration and visibility, she could enhance her potential for future success and recognition. With her ongoing commitment to research and innovation, she is well-positioned to make significant contributions to science and healthcare.

Publications top noted✍️

  • Authors: H Norouzi, K Khoshgard, F Akbarzadeh
    Year: 2018
    Citation: Norouzi H, Khoshgard K, Akbarzadeh F. In vitro outlook of gold nanoparticles in photo-thermal therapy: a literature review. Lasers in Medical Science. 33, 917-926.
  • Authors: F Akbarzadeh, K Khoshgard, L Hosseinzadeh, E Arkan, D Rezazadeh
    Year: 2018
    Citation: Akbarzadeh F, Khoshgard K, Hosseinzadeh L, Arkan E, Rezazadeh D. Investigating the cytotoxicity of folate-conjugated bismuth oxide nanoparticles on KB and A549 cell lines. Advanced Pharmaceutical Bulletin. 8(4), 627.
  • Authors: F Akbarzadeh, K Khoshgard, E Arkan, L Hosseinzadeh, …
    Year: 2018
    Citation: Akbarzadeh F, Khoshgard K, Arkan E, Hosseinzadeh L, et al. Evaluating the photodynamic therapy efficacy using 5-aminolevulinic acid and folic acid-conjugated bismuth oxide nanoparticles on human nasopharyngeal carcinoma cell line. Artificial Cells, Nanomedicine, and Biotechnology. 46(sup3), S514-S523.
  • Authors: N Amin, A Afkhami, L Hosseinzadeh, F Akbarzadeh, T Madrakian, …
    Year: 2020
    Citation: Amin N, Afkhami A, Hosseinzadeh L, Akbarzadeh F, Madrakian T, et al. Ratiometric bioassay and visualization of dopamine β-hydroxylase in brain cells utilizing a nanohybrid fluorescence probe. Analytica Chimica Acta. 1105, 187-196.
  • Authors: F Akbarzadeh, K Khoshgard
    Year: 2024
    Citation: Akbarzadeh F, Khoshgard K. Enhancement of the effect of novel targeted 5-aminolevulinic acid conjugated bismuth oxide nanoparticles-based photodynamic therapy by simultaneous radiotherapy on KB cells. Photodiagnosis and Photodynamic Therapy. 46, 104025.
  • Authors: F Akbarzadeh, K Khoshgard, L Hosseinzadeh, E Arkan
    Year: 2018
    Citation: Akbarzadeh F, Khoshgard K, Hosseinzadeh L, Arkan E. Cytotoxicity of 5-ALA-conjugated bismuth oxide nanoparticles on KB cell line. Iranian Journal of Medical Physics. 15(Special Issue-12th Iranian Congress).
  • Authors: F Akbarzadeh, K Khoshgard, L Hosseinzadeh, E Arkan, D Rezazadeh
    Year: 2018
    Citation: Akbarzadeh F, Khoshgard K, Hosseinzadeh L, Arkan E, Rezazadeh D. Investigating the cytotoxicity of folate and 5-aminolevulinic acid-conjugated bismuth oxide nanoparticles on KB and A549 cell lines.